Autoantibodies directed to centromere protein F in a patient with BRCA1 gene mutation

Fiona Moghaddas*, Fredrick Joshua, Roberta Taylor, Marvin J. Fritzler, Ban Hock Toh

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Downloads (Pure)

Abstract

Background: Autoantibodies directed to centromere protein F were first reported in 1993 and their association with malignancy has been well documented. Case: We present the case of a 48-year-old Caucasian female with a BRCA1 gene mutation associated with bilateral breast cancer. Antinuclear autoantibody immunofluorescence performed for workup of possible inflammatory arthropathy showed a high titre cell cycle related nuclear speckled pattern, with subsequent confirmation by addressable laser bead immunoassay of the target antigen as an immunodominant epitope at the C-terminus of centromere protein F. Conclusion: Here we review the current literature on centromere protein F, its association with breast cancer and present the first case of this antibody being identified in a person with a BRCA1 gene mutation.

Original languageEnglish
Article number84
Pages (from-to)1-4
Number of pages4
JournalBMC Research Notes
Volume9
DOIs
Publication statusPublished - 11 Feb 2016
Externally publishedYes

Bibliographical note

Copyright the Author(s) 2016. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • ALBIA
  • antinuclear antibody
  • BRCA1
  • CENP-F
  • malignancy

Fingerprint

Dive into the research topics of 'Autoantibodies directed to centromere protein F in a patient with BRCA1 gene mutation'. Together they form a unique fingerprint.

Cite this